Interleukin 6

Interleukin 6 (IL-6) is an interleukin that acts as both a pro-inflammatory cytokine and an anti-inflammatory myokine. In humans, it is encoded by the IL6 gene.

IL-6 is secreted by T cells and macrophages to stimulate immune response, e.g. during infection and after trauma, especially burns or other tissue damage leading to inflammation. IL-6 also plays a role in fighting infection, as IL-6 has been shown in mice to be required for resistance against bacterium Streptococcus pneumoniae.

In addition, osteoblasts secrete IL-6 to stimulate osteoclast formation. Smooth muscle cells in the tunica media of many blood vessels also produce IL-6 as a pro-inflammatory cytokine. IL-6's role as an anti-inflammatory cytokine is mediated through its inhibitory effects on TNF-alpha and IL-1, and activation of IL-1ra and IL-10.

Function

IL-6 is an important mediator of fever and of the acute phase response. It is capable of crossing the blood-brain barrier and initiating synthesis of PGE2 in the hypothalamus, thereby changing the body's temperature setpoint. In muscle and fatty tissue, IL-6 stimulates energy mobilization that leads to increased body temperature. IL-6 can be secreted by macrophages in response to specific microbial molecules, referred to as pathogen-associated molecular patterns (PAMPs). These PAMPs bind to an important group of detection molecules of the innate immune system, called pattern recognition receptors (PRRs), including Toll-like receptors (TLRs). These are present on the cell surface and intracellular compartments and induce intracellular signaling cascades that give rise to inflammatory cytokine production.

Podcasts:

PLAYLIST TIME:

Latest News for: interleukin-6

Edit

The Interleukin-2 Market is Set to Reach USD 4 Billion by 2034, Driven by IL-2 Targeting Fusion Proteins, Monoclonal antibodies, and Gene Therapies Across Immunology, Dermatology, Neurodegenerative Disorders, and Oncology | DelveInsight

PR Newswire 27 Mar 2025
Learn more about the IL-2 treatment landscape @ Interleukin-2 Therapeutic Landscape ... To know more about FDA-approved IL-2 inhibitors, visit @ Approved Interleukin-2 Drugs ... @ Interleukin-2 Market Report.
Edit

Interleukin-2 Market Size, Target Population, Competitive Landscape & Market Forecast to 2034: Japan Leads Interleukin-2 ...

Nasdaq Globe Newswire 20 Mar 2025
The Interleukin-2 (IL-2) market is set for significant expansion through 2034, driven by growing cancer and autoimmune disease cases, FDA approvals, and innovative pipeline therapies ... The Interleukin-2 ...
  • 1
×